Loading compound...
Kinase inhibitor
Linifanib is a small molecule drug currently being studied in clinical trials (Phase 3). It works by inhibiting several specific receptors, including those for growth factors and blood vessel growth, to help treat various types of cancer.
How it worksLinifanib works by blocking certain receptors in the body, such as those that help tumors grow new blood vessels or signal cells to divide.
Used for
Hepatocellular carcinoma (liver cancer)Renal cell carcinoma (kidney cancer)Colorectal adenocarcinoma (colon cancer)Rectum cancerBreast cancerMalignant colon neoplasmAge-related macular degenerationNon-small cell lung carcinoma
Conditions
Hepatocellular carcinomaRenal cell carcinomaColorectal adenocarcinomaRectum cancerBreast cancerMalignant colon neoplasmAge-related macular degenerationNon-small cell lung carcinoma
Class
Small moleculeKinase inhibitorVEGF inhibitorPDGF inhibitorFLT3 inhibitorHepaticRenalGastrointestinalRespiratoryOcular
How to take
Linifanib is still in the research and testing phases and is not yet widely approved for general use in all listed conditions.
Talk to your doctor
Questions to ask
- ·Is Linifanib appropriate for my specific type of cancer?
- ·What are the potential side effects of Linifanib?
- ·Are there any clinical trials for Linifanib available?
- ·How will Linifanib interact with my current medications?
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.
